TP
GILD icon

Tranquility Partners’s Gilead Sciences GILD Stock Holding History

Tranquility Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,193
Closed -$232K – 223
2021
Q4 		$232K Buy
3,193
+24
+0.8% +$1.65K 0.11% 195
2021
Q3 		$221K Buy
+3,169
New +$223K 0.11% 199
2020
Q3 		– Sell
-2,625
Closed -$202K – 152
2020
Q2 		$202K Buy
+2,625
New +$201K 0.19% 136

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tranquility Partners's GILD Position: Q1 2022 in Review

Tranquility Partners sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 3,193 shares — an estimated $232K sold.

Tranquility Partners first reported a position in GILD in Q2 2020 and held it in 3 quarters. The position peaked at $232K in Q4 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Tranquility Partners reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Tranquility Partners sold 3,193 Gilead Sciences shares in Q1 2022, an estimated $232K.
  • Tranquility Partners first reported a position in Gilead Sciences in Q2 2020 and held it in 3 quarters.
  • Tranquility Partners's Gilead Sciences position peaked at $232K in Q4 2021.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Tranquility Partners's 13F filing for Q1 2022, filed 29 Apr 2022.